Cargando…

Tumor T(1) Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model

PURPOSE: To assess whether T(1) relaxation time of tumors may be used to assess response to bevacizumab anti-angiogenic therapy. Procedures: 12 female nude mice bearing subcutaneous SKOV3ip1-LC ovarian tumors were administered bevacizumab (6.25ug/g, n=6) or PBS (control, n=6) therapy twice a week fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravoori, Murali K., Nishimura, Masato, Singh, Sheela P., Lu, Chunhua, Han, Lin, Hobbs, Brian P., Pradeep, Sunila, Choi, Hyun J., Bankson, James A., Sood, Anil K., Kundra, Vikas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476738/ https://www.ncbi.nlm.nih.gov/pubmed/26098849 http://dx.doi.org/10.1371/journal.pone.0131095

Ejemplares similares

New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
por: Ghaghada, Ketan B., et al.
Publicado: (2009)

Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent
por: Ravoori, M. K., et al.
Publicado: (2016)

Visualizing the Prostate Gland by MR Imaging in Young and Old Mice
por: Ravoori, Murali, et al.
Publicado: (2013)

The role of tumor microenvironment in resistance to anti-angiogenic therapy
por: Ma, Shaolin, et al.
Publicado: (2018)

Angiotensin II increases gene expression after selective intra-arterial adenovirus delivery in a rabbit model assessed using in vivo SSTR2-based reporter imaging
por: Singh, Sheela P., et al.
Publicado: (2016)

Noninvasive Assessment of Gene Transfer and Expression by In Vivo Functional and Morphologic Imaging in a Rabbit Tumor Model
por: Ravoori, Murali K., et al.
Publicado: (2013)

Correction: Noninvasive Assessment of Gene Transfer and Expression by In Vivo Functional and Morphologic Imaging in a Rabbit Tumor Model
por: Ravoori, Murali K., et al.
Publicado: (2013)

Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian Cancer
por: Mahner, Sven, et al.
Publicado: (2015)

Deletion of cyclooxygenase-2 inhibits K-ras–induced lung carcinogenesis
por: Pan, Yong, et al.
Publicado: (2015)

ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy
por: Yasukawa, Maya, et al.
Publicado: (2016)

Dependence of DCE-MRI biomarker values on analysis algorithm
por: Ng, Chaan S., et al.
Publicado: (2015)

Transformation of Human Mesenchymal Cells and Skin Fibroblasts into Hematopoietic Cells
por: Harris, David M., et al.
Publicado: (2011)

Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer
por: Loizzi, Vera, et al.
Publicado: (2017)

PBI-05204, a supercritical CO(2) extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway
por: Pan, Yong, et al.
Publicado: (2014)

Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model
por: Ravoori, Murali, et al.
Publicado: (2010)

Unexpectedly durable palliation of metastatic olfactory neuroblastoma using anti-angiogenic therapy with Bevacizumab
por: Dunbar, Erin M., et al.
Publicado: (2012)

B Cells as an Immune-Regulatory Signature in Ovarian Cancer
por: Gupta, Prachi, et al.
Publicado: (2019)

ERBB signaling in CTCs of ovarian cancer and glioblastoma
por: Geethadevi, Anjali, et al.
Publicado: (2017)

ADH1B promotes mesothelial clearance and ovarian cancer infiltration
por: Gharpure, Kshipra M., et al.
Publicado: (2018)

Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab
por: Mitsuhashi, Atsushi, et al.
Publicado: (2015)

Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy
por: Schuster, Cornelia, et al.
Publicado: (2018)

Bevacizumab in the treatment of ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2011)

Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization
por: Dratviman-Storobinsky, Olga, et al.
Publicado: (2009)

Anti-angiogenic therapy for ovarian cancer
por: García García, Yolanda, et al.
Publicado: (2020)

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2016)

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy
por: Bi, Jianling, et al.
Publicado: (2021)

Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies
por: McAlarnen, Lindsey A., et al.
Publicado: (2022)

Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment
por: Kumar, Sudhir, et al.
Publicado: (2022)

Influence of the vitrification solution on the angiogenic factors in vitrificated mouse ovarian tissue
por: Choi, Won-Jun, et al.
Publicado: (2013)

Bempegaldesleukin (BEMPEG; NKTR‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma
por: Hennessy, Marlene, et al.
Publicado: (2020)

AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma
por: Stegelmeier, Ashley A., et al.
Publicado: (2022)

Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein
por: Heydar, Hossein, et al.
Publicado: (2018)

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using (111)In-bevacizumab
por: Patel, Neel, et al.
Publicado: (2017)

Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications
por: Liu, Jiaxin, et al.
Publicado: (2019)

Markers of Angiogenesis in Ovarian Cancer
por: Merritt, William M., et al.
Publicado: (2007)

Influence of mouse strain on ovarian tissue recovery after engraftment with angiogenic factor
por: Fransolet, Maïté, et al.
Publicado: (2015)

Critical appraisal of bevacizumab in the treatment of ovarian cancer
por: Yoshida, Hiroyuki, et al.
Publicado: (2015)

Current status of bevacizumab in advanced ovarian cancer
por: Tomao, Federica, et al.
Publicado: (2013)

Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
por: Hamilton, Gerhard
Publicado: (2020)

Safety Analysis of Bevacizumab in Ovarian Cancer Patients
por: Wang, Yingwen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oc0gmvuqvhu4g79hfp4kpj38q1